Center for Vitreo-Retinal Diseases

The Center for Vitreo‑Retinal Diseases is a medical organization that focuses on the diagnosis and treatment of disorders affecting the vitreous humor and retina of the eye. Its clinical services include comprehensive eye examinations, imaging studies such as optical coherence tomography and fluorescein angiography, and medical therapies like intravitreal anti‑VEGF injections. Surgical interventions offered by the center encompass vitrectomy procedures, retinal detachment repair, macular hole surgery, and treatment of proliferative vitreoretinopathy. Patients receive care in an outpatient setting, with the ability to accommodate more complex cases that require hospital‑based operative facilities. The organization serves individuals referred by optometrists, general ophthalmologists, and other physicians seeking specialized retinal expertise. By concentrating exclusively on vitreoretinal pathology, the center provides a level of focused expertise that distinguishes it from broader ophthalmology practices.

The center’s distinguishing attribute is its specialization in vitreoretinal medicine, which requires physicians to complete additional fellowship training beyond general ophthalmology residency. This specialization enables the staff to manage complex retinal diseases such as diabetic retinopathy, age‑related macular degeneration, retinal vascular occlusions, and inherited retinal dystrophies. The organization adheres to federal health privacy regulations, including HIPAA, to safeguard patient information collected during diagnostic and therapeutic encounters. Its clinical workflow integrates advanced diagnostic imaging with real‑time surgical planning, allowing for precise localization of retinal pathology. The center often participates in clinical research and trials aimed at evaluating novel pharmacologic agents and surgical techniques for vitreoretinal disorders. This focus on both clinical excellence and investigative activity positions it as a referral hub for challenging retinal cases within its geographic service area.

On September 18, 2018, the Center for Vitreo‑Retinal Diseases experienced a ransomware attack that compromised servers containing patient data. The breach potentially exposed names, contact information, dates of birth, insurance details, health records, and Social Security numbers of Medicare beneficiaries. Although investigators found no evidence that the accessed data had been misused, the organization notified over 20,300 affected individuals about the incident. To assist those impacted, the center established a dedicated call center where patients could ask questions and receive guidance on protective measures. In response to the attack, the organization implemented additional security controls, including enhanced network monitoring, updated endpoint protection, and revised access management policies. These actions were intended to reduce the likelihood of similar incidents and to reinforce the safeguarding of sensitive health information moving forward.